EMA Product Specific GL [Regulatives / Guidelines]

posted by mmw – India, 2017-07-14 16:50 (2470 d 16:26 ago) – Posting: # 17548
Views: 9,455

Dear all,

EMA adopted a new batch of product specific guidances. Published on 10/07/2017:

Crizotinib
Elvitegravir / cobicistat / emtricitabine / te­no­fovir disoproxil
Elvitegravir
Emtricitabine, rilpivirine, tenofovir, disopro­xil
Vortioxetine

Thanks

MMW

Complete thread:

UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,663 registered users;
96 visitors (1 registered, 95 guests [including 6 identified bots]).
Forum time: 09:17 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5